Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07732374) titled 'Long-Term Outcomes Following HBOT' on July 23.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Summit Hyperbarics and Wellness

Condition: Traumatic Brain Injury Post-Concussive Symptoms Post-Traumatic Stress Disorder

Intervention: Drug: Hyperbaric Oxygen Therapy (HBOT)

Recruitment Status: Recruiting

Phase: Phase 2

Date of First Enrollment: June 18, 2026

Target Sample Size: 35

Countries of Recruitment: United States

To know more, visit https://clinicaltrials.gov/study/NCT077323...